참고문헌
- Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010;463:191-196. https://doi.org/10.1038/nature08658
- Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007;446:153-158. https://doi.org/10.1038/nature05610
- Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012;483:603-607. https://doi.org/10.1038/nature11003
- Greshock J, Bachman KE, Degenhardt YY, Jing J, Wen YH, Eastman S, et al. Molecular target class is predictive of in vitro response profile. Cancer Res 2010;70:3677-3686. https://doi.org/10.1158/0008-5472.CAN-09-3788
- McDermott U, Sharma SV, Dowell L, Greninger P, Montagut C, Lamb J, et al. Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. Proc Natl Acad Sci U S A 2007;104: 19936-19941. https://doi.org/10.1073/pnas.0707498104
- Kim N, He N, Kim C, Zhang F, Lu Y, Yu Q, et al. Systematic analysis of genotype-specific drug responses in cancer. Int J Cancer 2012;131:2456-2464. https://doi.org/10.1002/ijc.27529
- Kim N, Park H, He N, Lee HY, Yoon S. QCanvas: an advanced tool for data clustering and visualization of genomics data. Genomics Inform 2012;10:263-265. https://doi.org/10.5808/GI.2012.10.4.263
- Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011; 39:D945-D950. https://doi.org/10.1093/nar/gkq929
- Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci U S A 2003;100:776-781. https://doi.org/10.1073/pnas.0334858100
- Loeb KR, Loeb LA. Significance of multiple mutations in cancer. Carcinogenesis 2000;21:379-385. https://doi.org/10.1093/carcin/21.3.379
- Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499: 214-218. https://doi.org/10.1038/nature12213
- Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000;77:81-137.
- Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007;26:2157-2165. https://doi.org/10.1038/sj.onc.1210302
- Cowey CL, Rathmell WK. VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy. Curr Oncol Rep 2009;11:94-101. https://doi.org/10.1007/s11912-009-0015-5
- Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011;469:539-542. https://doi.org/10.1038/nature09639
- Pawlowski R, Mühl SM, Sulser T, Krek W, Moch H, Schraml P. Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer 2013;132:E11-E17. https://doi.org/10.1002/ijc.27822
- Lambert SR, Harwood CA, Purdie KJ, Gulati A, Matin RN, Romanowska M, et al. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. Int J Cancer 2012;131: E216-E226. https://doi.org/10.1002/ijc.27333
피인용 문헌
- Conditional inactivation of the mouse von Hippel–Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney vol.34, pp.20, 2015, https://doi.org/10.1038/onc.2014.197
- Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments vol.5, pp.1, 2015, https://doi.org/10.1038/srep09759
- Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development vol.11, pp.1, 2016, https://doi.org/10.1186/s13062-016-0125-6
- Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data vol.17, pp.S12, 2016, https://doi.org/10.1186/s12859-016-1190-7
- Clonal hematopoiesis in patients with dyskeratosis congenita vol.91, pp.12, 2016, https://doi.org/10.1002/ajh.24552
- EBT: a statistic test identifying moderate size of significant features with balanced power and precision for genome-wide rate comparisons vol.33, pp.17, 2017, https://doi.org/10.1093/bioinformatics/btx294
- Transcriptome modeling and phenotypic assays for cancer precision medicine vol.40, pp.8, 2017, https://doi.org/10.1007/s12272-017-0940-z
- Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir pp.00207136, 2017, https://doi.org/10.1002/ijc.31111
- Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families pp.1573-7217, 2017, https://doi.org/10.1007/s10549-017-4469-0
- Computational analysis reveals histotype-dependent molecular profile and actionable mutation effects across cancers vol.10, pp.1, 2018, https://doi.org/10.1186/s13073-018-0591-9
- MUC16 mutations improve patients’ prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment vol.7, pp.10, 2018, https://doi.org/10.1080/2162402X.2018.1487914
- A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction pp.1557-7430, 2018, https://doi.org/10.1089/dna.2018.4317
- MUC16 as a novel target for cancer therapy vol.22, pp.8, 2018, https://doi.org/10.1080/14728222.2018.1498845
- Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma pp.1432-1335, 2019, https://doi.org/10.1007/s00432-019-02861-y